Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

TLPH.US Logo

TLPH.US - Current Price

$1.03

Company Information

▼
Company Name
Talphera Inc.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US00444T2096
CIK: 0001427925
CUSIP: 00444T209
Currency: USD
Full Time Employees: 13
Phone: 650 216 3500
Website: https://talphera.com
Fiscal Year End: December
IPO Date: Feb 11, 2011
Description:

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.

Address:

1850 Gateway Drive, San Mateo, CA, United States, 94404

Directors & Officers

▼
Name Title Year Born
Mr. Vincent J. Angotti CEO & Director 1968
Mr. Raffi Mark Asadorian Chief Financial Officer 1969
Mr. Anil N. Dasu Chief Engineering Officer 1963
Dr. Shakil Aslam M.D. Chief Medical Officer 1965

Shares Statistics

▼
Shares Outstanding: 46.61M
Shares Float: 25.50M
% Insiders: 2,841.10%
% Institutions: 3,814.60%
Short % Float: 3.55%

Valuation Metrics

▼
Enterprise Value: $26.72M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $48.01M
EBITDA: $-15.16M
Book Value: $0.42
Earnings/Share: $-0.38
Profit Margin: 0.00%
Operating Margin: -342,200.00%
ROA (TTM): -31.46%
ROE (TTM): -86.48%
Revenue (TTM): $28.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2025 -0.11 -1.03 N/A 8,932.04%
Jun 30, 2025 -0.10 -0.14 N/A 2,857.14%
Mar 31, 2025 -0.07 -0.14 N/A 5,024.42%
Dec 31, 2024 -0.07 -0.16 N/A 5,625.00%
Sep 30, 2024 -0.13 -0.20 N/A 3,605.00%
Jun 30, 2024 -0.15 -0.23 N/A 3,647.83%
Mar 31, 2024 -0.16 -0.22 N/A 2,727.27%
Dec 31, 2023 -0.25 -0.20 N/A -2,500.00%
Sep 30, 2023 -0.08 -0.28 N/A 7,142.86%
Jun 30, 2023 -0.40 N/A N/A N/A
Mar 31, 2023 -0.75 -0.51 N/A -4,705.88%
Sep 30, 2022 -0.94 -1.20 N/A 2,166.67%
Jun 30, 2022 0.48 -0.08 N/A 74,000.00%
Mar 31, 2022 -0.06 -0.06 N/A 0.00%
Dec 31, 2021 -0.06 -0.07 N/A 769.23%
Sep 30, 2021 -0.07 -0.07 N/A 0.00%
Jun 30, 2021 -0.08 -0.08 N/A 0.00%
Mar 31, 2021 -0.08 -0.08 N/A 396.16%
Dec 31, 2020 -0.10 -0.10 N/A 319.46%
Sep 30, 2020 -0.10 -0.08 N/A -2,121.21%
Jun 30, 2020 -0.08 -0.13 N/A 3,846.15%
Mar 31, 2020 -0.20 -0.17 N/A -1,764.71%
Dec 31, 2019 -0.18 -0.20 N/A 1,000.00%
Sep 30, 2019 -0.16 -0.21 N/A 2,380.95%
Jun 30, 2019 -0.16 -0.21 N/A 2,380.95%
Mar 31, 2019 -0.17 -0.22 N/A 2,272.73%
Dec 31, 2018 -0.18 -0.20 N/A 1,000.00%
Sep 30, 2018 -0.21 -0.20 N/A -500.00%
Jun 30, 2018 -0.20 -0.20 N/A 0.00%
Mar 31, 2018 -0.23 -0.25 N/A 800.00%
Dec 31, 2017 -0.20 -0.20 N/A 0.00%
Sep 30, 2017 -0.20 -0.27 N/A 2,592.59%
Jun 30, 2017 -0.29 -0.28 N/A -357.14%
Mar 31, 2017 -0.34 -0.27 N/A -2,592.59%
Dec 31, 2016 -0.21 -0.24 N/A 1,250.00%
Sep 30, 2016 -0.21 -0.23 N/A 869.57%
Jun 30, 2016 -0.25 -4.40 N/A 9,431.82%
Mar 31, 2016 -0.24 -4.08 N/A 9,411.76%
Dec 31, 2015 -0.25 -0.10 N/A -15,000.00%
Sep 30, 2015 0.12 -0.23 N/A 15,217.39%
Jun 30, 2015 0.11 -0.26 N/A 14,230.77%
Mar 31, 2015 -0.20 -0.28 N/A 2,857.14%
Dec 31, 2014 -0.23 -0.30 N/A 2,333.33%
Sep 30, 2014 -0.32 -0.22 N/A -4,545.45%
Jun 30, 2014 -0.24 -0.26 N/A 769.23%
Mar 31, 2014 -0.22 -0.23 N/A 434.78%
Dec 31, 2013 -0.22 -0.17 N/A -2,941.18%
Sep 30, 2013 -0.26 -0.19 N/A -3,684.21%
Jun 30, 2013 -9.36 N/A N/A N/A
Mar 31, 2013 -6.87 N/A N/A N/A
Dec 31, 2012 -8.20 N/A N/A N/A
Sep 30, 2012 -7.58 N/A N/A N/A
Jun 30, 2012 -6.98 N/A N/A N/A
Mar 31, 2012 -7.21 N/A N/A N/A
Dec 31, 2011 -7.35 N/A N/A N/A
Sep 30, 2011 -5.92 N/A N/A N/A
Jun 30, 2011 -4.92 N/A N/A N/A
Mar 31, 2011 -5.97 N/A N/A N/A
Dec 31, 2010 -3.64 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $8.86M $N/A $18.24M $10.24M $8.00M
2023-12-31 $5.72M $N/A $20.40M $6.29M $14.11M
2022-12-31 $15.28M $N/A $47.49M $25.67M $21.81M
2021-12-31 $7.66M $N/A $77.89M $113.79M $-35.89M
2020-12-31 $27.27M $N/A $66.30M $122.05M $-55.75M
2019-12-31 $14.68M $N/A $91.36M $132.77M $-41.42M
2018-12-31 $87.98M $N/A $120.53M $116.28M $4.25M
2017-12-31 $52.90M $N/A $75.55M $112.06M $-36.51M
2016-12-31 $80.31M $N/A $99.99M $105.33M $-5.34M
2015-12-31 $107.92M $N/A $127.79M $94.67M $33.11M
2014-12-31 $60.04M $N/A $86.42M $39.76M $46.66M
2013-12-31 $88.40M $N/A $110.03M $36.87M $73.16M
2012-12-31 $47.93M $N/A $64.52M $30.67M $33.85M
2011-12-31 $7.79M $N/A $40.84M $23.37M $17.47M
2010-12-31 $3.06M $N/A $6.83M $72.72M $-65.89M
2009-12-31 $7.15M $N/A $14.49M $67.49M $-52.99M
2008-12-31 $6.07M $N/A $22.68M $56.01M $-33.34M
2007-12-31 $N/A $N/A $N/A $N/A $N/A

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 05, 2024 N/A N/A N/A N/A N/A N/A
Nov 27, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist